Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men

Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men Anxiolytic and sedative effects of neuropeptide Y (NPY) are thought to involve inhibition of corticotropin-releasing hormone (CRH). Enhanced secretion of CRH plays a critical role in the pathophysiology of major depression, characterized by sleep disturbances, anxiety and loss of appetite. We examined for the first time in young men effects of intravenous injections of NPY (4×50 or 100 μg, n =9 and 11, respectively, at 22.00, 23.00, 24.00 and 01.00 compared to saline) on the sleep electroencephalogram (EEG; recorded from 23.00 to 07.00) and nocturnal secretion of adrenocorticotrophic hormone (ACTH), cortisol, growth hormone (GH), prolactin and leptin. Repeated measures MANOVA showed that ACTH secretion during the first half of the night was reduced by the lower dose of NPY only ( F =8.7, p <0.05), while cortisol secretion during the second half of the night was reduced regardless of the dose ( F =7.9, p <0.05). Regardless of the dose, NPY enhanced sleep period time and stage 2 sleep ( F =12.8 and 5.4, each p <0.05), and also reduced sleep latency and time awake ( F =4.9 and 4.4, each p <0.05) and modulated REM sleep. In summary, NPY promotes sleep and inhibits the hypothalamo–pituitary–adrenocortical (HPA) axis in humans, pointing to a possible role of NPY agonists for the development of novel treatment strategies for affective disorders. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Neuropharmacology Elsevier

Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men

Loading next page...
 
/lp/elsevier/neuropeptide-y-promotes-sleep-and-inhibits-acth-and-cortisol-release-E0AleejB1m
Publisher
Elsevier
Copyright
Copyright © 2000 Elsevier Science Ltd
ISSN
0028-3908
eISSN
1873-7064
DOI
10.1016/S0028-3908(00)00057-5
Publisher site
See Article on Publisher Site

Abstract

Anxiolytic and sedative effects of neuropeptide Y (NPY) are thought to involve inhibition of corticotropin-releasing hormone (CRH). Enhanced secretion of CRH plays a critical role in the pathophysiology of major depression, characterized by sleep disturbances, anxiety and loss of appetite. We examined for the first time in young men effects of intravenous injections of NPY (4×50 or 100 μg, n =9 and 11, respectively, at 22.00, 23.00, 24.00 and 01.00 compared to saline) on the sleep electroencephalogram (EEG; recorded from 23.00 to 07.00) and nocturnal secretion of adrenocorticotrophic hormone (ACTH), cortisol, growth hormone (GH), prolactin and leptin. Repeated measures MANOVA showed that ACTH secretion during the first half of the night was reduced by the lower dose of NPY only ( F =8.7, p <0.05), while cortisol secretion during the second half of the night was reduced regardless of the dose ( F =7.9, p <0.05). Regardless of the dose, NPY enhanced sleep period time and stage 2 sleep ( F =12.8 and 5.4, each p <0.05), and also reduced sleep latency and time awake ( F =4.9 and 4.4, each p <0.05) and modulated REM sleep. In summary, NPY promotes sleep and inhibits the hypothalamo–pituitary–adrenocortical (HPA) axis in humans, pointing to a possible role of NPY agonists for the development of novel treatment strategies for affective disorders.

Journal

NeuropharmacologyElsevier

Published: Jul 1, 2000

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off